NASDAQ:ATOS   Atossa Therapeutics, Inc.
Atossa Therapeutics has potentially come out with a new and innovative treatment for cancer. It isn't a sure thing, but once the public hears more about the drug and they start to get into late-stage clinical trials, this stock could skyrocket. Good Luck!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.